Teen tobacco use falls to 25-year low as fewer pick up e-cigarettes

Teen tobacco use falls to 25-year low as fewer pick up e-cigarettes


In this photo illustration, ZYN nicotine cases and pouches are seen on a table on January 29, 2024 in New York City. 

Michael M. Santiago | Getty Images

Tobacco product use among middle and high school students has dropped to a 25-year low, the Centers for Disease Control and Prevention and the U.S. Food and Drug Administration announced on Thursday.

The CDC and FDA recorded data on youth tobacco product use through the National Youth Tobacco Survey, which found that 2.25 million middle and high school students reported they had used any tobacco product in the last 30 days, down from 2.8 million in 2023.

The drop reflected a decline in students who said they were using electronic cigarettes, down to 1.63 million in 2024 from 2.13 million in 2023.

“We’re headed in the right direction when it comes to reducing tobacco product use among our nation’s youth,” Brian King, director of the FDA’s Center for Tobacco Products, said in a press release on Thursday. “But we can’t take our foot off the gas. Continued vigilance is needed to continue to reduce all forms of tobacco product use among youth. Addressing disparities remains an essential part of these efforts to ensure that we don’t leave anyone behind.”

Female students reported the biggest decline in use across the board, and Hispanic students also reported a drop in use of any tobacco product. Evidence-based strategies, including price increases, media campaigns and smoke-free policies, are likely part of what caused tobacco product use to drop, according to the agencies.

E-cigarettes continue to be the most used among students who reported tobacco product use, at 5.9%, but nicotine pouches are now the second most commonly used tobacco product, at 1.8%, followed by cigarettes at 1.4%.

Nicotine pouch use actually grew among students, though not enough to be considered significant, from 1.2% in 2023 to 1.8% in 2024, the CDC said in September.

“Youth use of tobacco products in any form — including e-cigarettes and nicotine pouches — is unsafe,” Deirdre Lawrence Kittner, the director of the CDC’s office on smoking and health, said in a press release in September. “It’s essential that we remain vigilant and committed to public health efforts to ensure all youth can live healthy, tobacco-free lives.”

Zyn was the most popular nicotine pouch brand, at 68.7%, compared with the next most popular brand On at 14.2%.

Zyn, the oral nicotine pouch brand owned by Philip Morris International, exploded in popularity on social media earlier this year which led to a nationwide shortage. Philip Morris in July announced plans to invest $600 million into a new Zyn production facility in Colorado in response to the spike in demand.

The survey was distributed among 29,861 students from 283 schools from Jan. 22 to May 22.



Source

Congressional hemp restrictions threaten  billion industry, sending companies scrambling
Health

Congressional hemp restrictions threaten $28 billion industry, sending companies scrambling

The hemp industry is bracing for layoffs, production reductions and billions in lost revenue after Congress passed a government funding bill late Wednesday containing a surprise provision that will ban nearly all hemp-derived consumer products. Hemp, a derivative of the cannabis plant, was legalized in the 2018 Farm Bill for industrial uses like rope, textiles […]

Read More
Cheaper medicines, free beach trips: U.S. health plans tap prescriptions that feds say are illegal
Health

Cheaper medicines, free beach trips: U.S. health plans tap prescriptions that feds say are illegal

Every step is a struggle for Bruce Zimmerman, whose health has been deteriorating since he was diagnosed with multiple sclerosis eight years ago. In 2019, Zimmerman said, his then-employer offered him an opportunity that sounded irresistible: He and his wife, Becky, could take all-expense-paid trips to the Cayman Islands and the Bahamas to retrieve the medication […]

Read More
Healthy Returns: Novo Nordisk boosts the case for its upcoming obesity pill with additional data
Health

Healthy Returns: Novo Nordisk boosts the case for its upcoming obesity pill with additional data

A view shows a Novo Nordisk sign outside its office in Bagsvaerd, on the outskirts of Copenhagen, Denmark, on July 14, 2025. Tom Little | Reuters A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. All […]

Read More